WGS

45.4607.68%
BM

Bryan M. Dechairo

Chief Technology & Innovation Officer

Dr. Bryan M. Dechairo, Ph.D., is Chief Operating Officer of GeneDx, Inc. Dr. Dechairo was Chief Operating Officer of GeneDx Holdings Corp. from January 2, 2025 and serves as Chief Technology and Innovation Officer. He oversees Product & Technology, Operations, Medical Affairs, Innovation and the Program Management teams at GeneDx. He is pivotal in driving operational excellence as company enters the next phase of commercial growth. He has experience in exploratory and commercial diagnostic businesses, driving the development of revenue-generating clinical innovations that enhance patient outcomes. He served as President, Chief Executive Officer and Director at Sherlock Biosciences, Inc. since July 2021 until January, 2025 where he had successfully transformed company from a research-stage start-up into a commercial operation. He served as Non-Executive Independent Director at Biocartis Group NV since February 21, 2023 until January, 2025. He was Executive Vice President of Clinical Development at Myriad Genetics, Inc. since August 30, 2017 until 2020. Dr. Dechairo has experience in healthcare technology and a background in pharmaceutical development. He joined Myriad in August 2012. He served as Senior Vice President of Medical Affairs & Clinical Development at Assurex Health, Inc. He served as Senior Vice President of Medical Affairs and Strategic Alliances at Assurex Health, Inc. since December 2012 and also served as its CSO, CMO and Senior Vice President of R&D at Assurex Health. Dr. Dechairo served as Head of extramural research and development at Franklin Lakes, N.J.-based Medco Research Institute. Before joining the Assurex Health team, Dr. Dechairo served as the Head of Diagnostic Reimbursement Evaluation and Extramural Research and Development for Medco Health Solutions. He also served on the board of directors for the National Alliance on Mental Illness and educated and mentored the next generation of clinical leaders through his role as assistant professor of pharmacology at the University of Cincinnati. Dr. Dechairo also served as the Neuroscience Lead and Director of Molecular Medicine at Pfizer Global Research and Development. Dr. Dechairo earned a Ph.D. in Common Complex Human Genetics from the Institute of Child Health at University College London and a B.A. in Integrative Biology from the University of California, Berkeley.

Positions